CIDRZ Conducts TSwaY Study to Evaluate Tongue Swabs for TB Diagnosis

Breakthrough TB among people living with HIV on TB preventive therapy
March 18, 2025
CIDRZ Participates in TB Vaccine Trial through Phase 3
March 20, 2025

CIDRZ Conducts TSwaY Study to Evaluate Tongue Swabs for TB Diagnosis

The Centre for Infectious Disease Research in Zambia (CIDRZ) is conducting a Tongue Swab Tuberculosis Diagnostic Yield (TSwaY) Study supported by Bill and Melinda Gates Foundation.

The TSwaY Study aims to evaluate the diagnostic yield, cost-effectiveness, accessibility, and usability of tongue swabs for diagnosing active Tuberculosis (TB) in Zambia, Uganda, Philippines, and Vietnam.

The study compares tongue- and sputum-based molecular testing for TB among adults, adolescents, and children with or without HIV. Preliminary data suggests that although tongue swabs may have lower sensitivity, if successful, this method could be an important alternative to sputum and may benefit patients who are unable to produce sputum, improving diagnosis and faster access to lifesaving TB treatment.

Comments are closed.

Facebook
Twitter
YouTube
LinkedIn
Instagram